Michelle M. Miller - Search Results

Year	Number of Results
2011	1
2012	3
2013	4
2014	2
2015	1
2016	1
2017	1
2020	1
2021	1
2023	0

1

Multiple receptors shape the estrogen response pathway and are critical considerations for the future of in vitro-based risk assessment efforts.

Miller MM, McMullen PD, Andersen ME, Clewell RA. Miller MM, et al. Crit Rev Toxicol. 2017 Aug;47(7):564-580. doi: 10.1080/10408444.2017.1289150. Epub 2017 Jul 4. Crit Rev Toxicol. 2017. PMID: 28675057 Review.

2

Optimization and qualification of an assay that demonstrates that a FimH vaccine induces functional antibody responses in women with histories of urinary tract infections.

Starks CM, Miller MM, Broglie PM, Cubbison J, Martin SM, Eldridge GR. Starks CM, et al. Among authors: miller mm. Hum Vaccin Immunother. 2021 Jan 2;17(1):283-292. doi: 10.1080/21645515.2020.1770034. Epub 2020 Jul 23. Hum Vaccin Immunother. 2021. PMID: 32701396 Free PMC article.

3

Infection with feline immunodeficiency virus directly activates CD4+ CD25+ T regulatory cells.

Miller MM, Fogle JE, Tompkins MB. Miller MM, et al. J Virol. 2013 Aug;87(16):9373-8. doi: 10.1128/JVI.00996-13. Epub 2013 Jun 12. J Virol. 2013. PMID: 23760252 Free PMC article.

4

T-cell factor/β-catenin activity is suppressed in two different models of autosomal dominant polycystic kidney disease.

Miller MM, Iglesias DM, Zhang Z, Corsini R, Chu L, Murawski I, Gupta I, Somlo S, Germino GG, Goodyer PR. Miller MM, et al. Kidney Int. 2011 Jul;80(2):146-53. doi: 10.1038/ki.2011.56. Epub 2011 Mar 9. Kidney Int. 2011. PMID: 21389971 Free PMC article.

5

Editor's Highlight: Development of an In vitro Assay Measuring Uterine-Specific Estrogenic Responses for Use in Chemical Safety Assessment.

Miller MM, Alyea RA, LeSommer C, Doheny DL, Rowley SM, Childs KM, Balbuena P, Ross SM, Dong J, Sun B, Andersen MA, Clewell RA. Miller MM, et al. Toxicol Sci. 2016 Nov;154(1):162-173. doi: 10.1093/toxsci/kfw152. Epub 2016 Aug 7. Toxicol Sci. 2016. PMID: 27503385 Free PMC article.

6

Human intravenous immunoglobulin (hIVIG) inhibits anti-CD32 antibody binding to canine DH82 cells and canine monocytes in vitro.

Sibley TA, Miller MM, Fogle JE. Sibley TA, et al. Among authors: miller mm. Vet Immunol Immunopathol. 2013 Feb 15;151(3-4):229-34. doi: 10.1016/j.vetimm.2012.11.013. Epub 2012 Nov 30. Vet Immunol Immunopathol. 2013. PMID: 23276750

7

Administration of Fozivudine tidoxil as a single-agent therapeutic during acute feline immunodeficiency virus infection does not alter chronic infection.

Miller MM, Fogle JE. Miller MM, et al. Viruses. 2012 Jun;4(6):954-62. doi: 10.3390/v4060954. Epub 2012 Jun 7. Viruses. 2012. PMID: 22816034 Free PMC article.

8

Modulating DNA methylation in activated CD8+ T cells inhibits regulatory T cell-induced binding of Foxp3 to the CD8+ T Cell IL-2 promoter.

Miller MM, Akaronu N, Thompson EM, Hood SF, Fogle JE. Miller MM, et al. J Immunol. 2015 Feb 1;194(3):990-8. doi: 10.4049/jimmunol.1401762. Epub 2014 Dec 29. J Immunol. 2015. PMID: 25548225 Free PMC article.

9

CD4+CD25+ T regulatory cells activated during feline immunodeficiency virus infection convert T helper cells into functional suppressors through a membrane-bound TGFβ / GARP-mediated mechanism.

Miller MM, Petty CS, Tompkins MB, Fogle JE. Miller MM, et al. Virol J. 2014 Jan 18;11:7. doi: 10.1186/1743-422X-11-7. Virol J. 2014. PMID: 24438223 Free PMC article.

10

Feline glycoprotein A repetitions predominant anchors transforming growth factor beta on the surface of activated CD4(+)CD25(+) regulatory T cells and mediates AIDS lentivirus-induced T cell immunodeficiency.

Miller MM, Fogle JE, Ross P, Tompkins MB. Miller MM, et al. AIDS Res Hum Retroviruses. 2013 Apr;29(4):641-51. doi: 10.1089/aid.2012.0322. Epub 2013 Feb 1. AIDS Res Hum Retroviruses. 2013. PMID: 23373523 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results